Home NDC 43825-102-03 Ofirmev
Product NDC 43825-102
Requested package NDC 43825-102-03
11-digit product format 438250102
Labeler code 43825
Product ID 43825-102_c5662877-ba4e-4f2b-a64e-3ecab2358a53
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acetaminophen
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Mallinckrodt Hospital Products Inc.
Application NDA022450
Marketing category NDA
Marketing start 2010-11-08
Marketing end 2022-07-31
Substance ACETAMINOPHEN
Active strength 10 mg/mL
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022450-001 OFIRMEV ACETAMINOPHEN 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022450-001 10383834 2028-11-13 U-2262 2019-09-18 N022450-001 10383834 2028-11-13 U-2621 2019-09-18 N022450-001 9610265 2028-11-13 U-2263 2017-05-04 N022450-001 9987238 2028-11-13 U-2261 2018-06-13 N022450-001 10383834*PED 2029-05-13 Pediatric extension N022450-001 9610265*PED 2029-05-13 Pediatric extension N022450-001 9987238*PED 2029-05-13 Pediatric extension N022450-001 9399012 2031-09-11 U-2261 2016-08-08 N022450-001 9399012 2031-09-11 U-2262 2016-08-08 N022450-001 9399012*PED 2032-03-11 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2010-11-02 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2010-11-02 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022450-001 OFIRMEV 1GM/100ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2010-11-02 e64feba35796…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 10 · 396 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N022450-001 10383834 2028-11-13 U-2262 2019-09-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 10383834 2028-11-13 U-2621 2019-09-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 9610265 2028-11-13 U-2263 2017-05-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 9987238 2028-11-13 U-2261 2018-06-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 10383834*PED 2029-05-13 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 9610265*PED 2029-05-13 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 9987238*PED 2029-05-13 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 9399012 2031-09-11 U-2262 2016-08-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 9399012 2031-09-11 U-2261 2016-08-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022450-001 9399012*PED 2032-03-11 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022450-001 10383834 2028-11-13 U-2262 2019-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 10383834 2028-11-13 U-2621 2019-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 9610265 2028-11-13 U-2263 2017-05-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 9987238 2028-11-13 U-2261 2018-06-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 10383834*PED 2029-05-13 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 9610265*PED 2029-05-13 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 9987238*PED 2029-05-13 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 9399012 2031-09-11 U-2262 2016-08-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 9399012 2031-09-11 U-2261 2016-08-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022450-001 9399012*PED 2032-03-11 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 10383834 2028-11-13 U-2262 2019-09-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 10383834 2028-11-13 U-2621 2019-09-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 9610265 2028-11-13 U-2263 2017-05-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 9987238 2028-11-13 U-2261 2018-06-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 10383834*PED 2029-05-13 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 9610265*PED 2029-05-13 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 9987238*PED 2029-05-13 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 9399012 2031-09-11 U-2262 2016-08-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 9399012 2031-09-11 U-2261 2016-08-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022450-001 9399012*PED 2032-03-11 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022450-001 10383834 2028-11-13 U-2262 2019-09-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 10383834 2028-11-13 U-2621 2019-09-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 9610265 2028-11-13 U-2263 2017-05-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 9987238 2028-11-13 U-2261 2018-06-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 9610265*PED 2029-05-13 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 9987238*PED 2029-05-13 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 9399012 2031-09-11 U-2262 2016-08-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 9399012 2031-09-11 U-2261 2016-08-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022450-001 9399012*PED 2032-03-11 Pediatric extension 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022450-001 10383834 2028-11-13 U-2262 2019-09-18 fd3edfee7708…
Observed Orange Book exclusivity history# DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ACETAMINOPHEN ACTIVE INGREDIENT 362O9ITL9D OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 ACETAMINOPHEN ACTIVE MOIETY 362O9ITL9D OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 CYSTEINE HYDROCHLORIDE INACTIVE INGREDIENT ZT934N0X4W OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 MANNITOL INACTIVE INGREDIENT 3OWL53L36A OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 NITROGEN INACTIVE INGREDIENT N762921K75 OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 SODIUM PHOSPHATE, DIBASIC INACTIVE INGREDIENT GR686LBA74 OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11 WATER INACTIVE INGREDIENT 059QF0KO0R OFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 11
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 43825-102-03 43825010203 24 BAG in 1 CARTON (43825-102-03) > 100 mL in 1 BAG 24 bag 2017-01-27 0000-00-00 No No Current